Cite
HARVARD Citation
Amoury, M. et al. (2016). Granzyme B-based cytolytic fusion protein targeting EpCAM specifically kills triple negative breast cancer cells in vitro and inhibits tumor growth in a subcutaneous mouse tumor model. Cancer letters. 372 (2), pp. 201-209. [Online].